📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection (2022)

First Author: Gerber P

Attributed to: MRC Transition Support CSF Nicholas Matheson funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.90760

Publication URI: https://www.repository.cam.ac.uk/handle/1810/343348

Type: Journal Article/Review